Improved Fc fusion proteins

Details for Australian Patent Application No. 2004224122 (hide)

Owner Apogenix Biotechnology AG Deutsches Krebsforschungszentrum Stiftung Des Offenftlichen Rechts

Inventors Walczak, Henning

Agent Davies Collison Cave

Pub. Number AU-A-2004224122

PCT Pub. Number WO2004/085478

Priority 03006949.6 26.03.03 EP

Filing date 26 March 2004

Wipo publication date 7 October 2004

International Classifications

C07K 014/525 Peptides having more than 20 amino acids

C07K 014/705 Peptides having more than 20 amino acids

C07K 014/54 Peptides having more than 20 amino acids

C07K 014/475 Peptides having more than 20 amino acids

C07K 014/715 Peptides having more than 20 amino acids

C07K 014/52 Peptides having more than 20 amino acids

C07K 014/47 Peptides having more than 20 amino acids

C07K 019/00 Hybrid peptides

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/085478 Priority application(s): WO2004/085478

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224123-Treatment of viral infections

2004224118-Method of depositing functional films on substrates such as glass sheets and film-coating machine for implementing said method